Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N; HERS Research Group..

JAMA. 2002 Jul 3;288(1):49-57. Erratum in: JAMA 2002 Sep 4;288(9):1064.

PMID:
12090862
2.
3.

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, Knopp R, Lowery M, Satterfield S, Schrott H, Vittinghoff E, Hunninghake D; HERS Research Group..

JAMA. 2002 Jul 3;288(1):58-66.

PMID:
12090863
4.

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.

Shlipak MG, Simon JA, Vittinghoff E, Lin F, Barrett-Connor E, Knopp RH, Levy RI, Hulley SB.

JAMA. 2000 Apr 12;283(14):1845-52.

PMID:
10770146
5.

Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS).

Herrington DM, Vittinghoff E, Lin F, Fong J, Harris F, Hunninghake D, Bittner V, Schrott HG, Blumenthal RS, Levy R; HERS Study Group..

Circulation. 2002 Jun 25;105(25):2962-7.

6.

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators..

JAMA. 2002 Jul 17;288(3):321-33.

PMID:
12117397
7.

Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.

Grady D, Applegate W, Bush T, Furberg C, Riggs B, Hulley SB.

Control Clin Trials. 1998 Aug;19(4):314-35.

PMID:
9683309
8.

The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: the Heart and Estrogen-Progestin Replacement Study (HERS).

Simon JA, Lin F, Vittinghoff E, Bittner V; Heart and Estrogen-Progestin Replacement Study (HERS) Research Group..

Ann Epidemiol. 2006 Feb;16(2):138-45. Epub 2005 Jul 21.

PMID:
16039873
9.

Estrogen plus progestin and the risk of coronary heart disease.

Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M; Women's Health Initiative Investigators..

N Engl J Med. 2003 Aug 7;349(6):523-34.

11.

Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS).

Shlipak MG, Chaput LA, Vittinghoff E, Lin F, Bittner V, Knopp RH, Hulley SB; Heart and Estrogen/progestin Replacement Study Investigators..

Am Heart J. 2003 Nov;146(5):870-5.

PMID:
14597937
12.

Creatinine levels and cardiovascular events in women with heart disease: do small changes matter?

Shlipak MG, Stehman-Breen C, Vittinghoff E, Lin F, Varosy PD, Wenger NK, Furberg CD; Heart and Estrogen/Progestin Replacement Study (HERS) Investigators..

Am J Kidney Dis. 2004 Jan;43(1):37-44.

PMID:
14712425
13.

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S; Women's Health Initiative Steering Committee..

JAMA. 2004 Apr 14;291(14):1701-12.

PMID:
15082697
14.

Predictors of heart failure among women with coronary disease.

Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Hulley SB, Grady D, Shlipak MG.

Circulation. 2004 Sep 14;110(11):1424-30. Epub 2004 Sep 7.

15.

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.

Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ.

Ann Intern Med. 2000 Dec 19;133(12):933-41.

PMID:
11119394
16.

Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial.

Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA; Heart and Estrogen/Progestin Replacement Study (HERS) Research Group..

JAMA. 2002 Feb 6;287(5):591-7.

PMID:
11829697
17.

Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial.

Toh S, Hernández-Díaz S, Logan R, Rossouw JE, Hernán MA.

Ann Intern Med. 2010 Feb 16;152(4):211-7. doi: 10.7326/0003-4819-152-4-201002160-00005.

18.

Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.

Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, Hendrix SL, Pettinger M, Heckbert SR, Greep N, Crawford S, Eaton CB, Kostis JB, Caralis P, Prentice R; Women's Health Initiative Investigators..

Arch Intern Med. 2006 Feb 13;166(3):357-65. Erratum in: Arch Intern Med. 2006 Apr 10;166(7):759.

PMID:
16476878
19.

Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.

Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ, Wactawski-Wende J, Jackson RD, Limacher M, Margolis KL, Wassertheil-Smoller S, Beresford SA, Cauley JA, Eaton CB, Gass M, Hsia J, Johnson KC, Kooperberg C, Kuller LH, Lewis CE, Liu S, Martin LW, Ockene JK, O'Sullivan MJ, Powell LH, Simon MS, Van Horn L, Vitolins MZ, Wallace RB.

JAMA. 2013 Oct 2;310(13):1353-68. doi: 10.1001/jama.2013.278040.

20.

Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS).

Bushnell CD, Newby LK, Goldstein LB, Lin F, Yaffe K, Simon JA.

Neurology. 2004 Mar 23;62(6):968-70.

PMID:
15037702

Supplemental Content

Support Center